U.S. flag

An official website of the United States government

NM_000900.5(MGP):c.56G>T (p.Cys19Phe) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Nov 17, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001877559.11

Allele description [Variation Report for NM_000900.5(MGP):c.56G>T (p.Cys19Phe)]

NM_000900.5(MGP):c.56G>T (p.Cys19Phe)

Gene:
MGP:matrix Gla protein [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12p12.3
Genomic location:
Preferred name:
NM_000900.5(MGP):c.56G>T (p.Cys19Phe)
Other names:
c.56G>T:p.Cys19Phe
HGVS:
  • NC_000012.12:g.14885736C>A
  • NG_023331.2:g.5184G>T
  • NM_000900.3:c.56G>T
  • NM_000900.5:c.56G>TMANE SELECT
  • NM_001190839.3:c.56G>T
  • NP_000891.2:p.Cys19Phe
  • NP_001177768.1:p.Cys19Phe
  • NC_000012.11:g.15038670C>A
  • NG_023331.1:g.5184G>T
Protein change:
C19F
Links:
dbSNP: rs1555094473
NCBI 1000 Genomes Browser:
rs1555094473
Molecular consequence:
  • NM_000900.5:c.56G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001190839.3:c.56G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002142662Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Nov 17, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Specific heterozygous variants in MGP lead to endoplasmic reticulum stress and cause spondyloepiphyseal dysplasia.

Gourgas O, Lemire G, Eaton AJ, Alshahrani S, Duker AL, Li J, Carroll RS, Mackenzie S, Nikkel SM; Care4Rare Canada Consortium, Bober MB, Boycott KM, Murshed M.

Nat Commun. 2023 Nov 3;14(1):7054. doi: 10.1038/s41467-023-41651-6. Erratum in: Nat Commun. 2024 Apr 30;15(1):3655. doi: 10.1038/s41467-024-47898-x.

PubMed [citation]
PMID:
37923733
PMCID:
PMC10624854

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002142662.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This sequence change replaces cysteine, which is neutral and slightly polar, with phenylalanine, which is neutral and non-polar, at codon 19 of the MGP protein (p.Cys19Phe). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant MGP-related spondyloepiphyseal dysplasia (PMID: 37923733). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 1373923). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects MGP function (PMID: 37923733). This variant disrupts the p.Cys19 amino acid residue in MGP. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 37923733). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024